List Of New Hair Loss Treatment 2023. Web the food and drug administration (fda) originally approved olumiant (baricitinib) in 2018 to treat rheumatoid arthritis. Web a hair loss researcher says 2022 was actually a very big year. a whole new class of drugs came to market to treat a common, patchy hair loss condition.

With some conditions, such as patchy hair loss (alopecia areata), hair may regrow without treatment within a year. Manage thyroid disease or other medical conditions that could result in hair loss. Food and drug administration approved olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a disorder that often.